A suite of Population Reporting searches for EMIS, created by the CDRC can be used identify patients in your practice who might benefit from lipid lowering or optimisation of treatment.
To enable actioning of these Population Reporting searches with guided instruction for patient care, please use the CDRC Lipid Management Template which can be accessed using the CDRC Precision Launcher. This holistic tool allows for accurate assessment, coding and management of patients to help meet best practice, QoF and PCN DES IIF indicators.
Accessing the Population Reporting Searches:
To access the CDRC Lipids Population Reporting Searches on EMIS, you will need to download and import the following .zip file:
If you have not performed this process before, please refer to the Download/ Import guide below, which provides you with step-by-step instructions on how to Download and Import .zip files into EMIS:
You can check whether you have the most up-to-date version by reviewing the date on the .zip file. Any updates to the Population Reporting searches will be communicated to CDRC Precision users via the mailing list for the CDRC. To ensure you stay up to date with the latest information, please sign up to the mailing list at http://eepurl.com/9131L
Guidance on the Population Reporting Searches
The primary Population Reporting searches in the .zip file are highlighted below along with information that explains the patients that these searches return and possible actions to take.
Lipid Screening
| Search Name | Search Description |
| ?Lipids 1.0 Screening – Target CVD Risk Assessment (estimated risk is >10%) | This is a list of patients who have an estimated QRisk2 calculated (uncoded) who may be eligible for a targeted CVD Risk assessment. |
| ?Lipids 1.1 Screening – Target CVD Risk Assessment – eligible for NHS Healthcheck | This is a subdivision of the parent search that highlights those that you could recall for an NHS Healthcheck. |
| ?Lipids 1.2 Screening – Target CVD Risk Assessment – has LTC | This is a subdivision of the parent search that highlights those that will be recalled for an LTC review (excluding respiratory reviews). |
| ?Lipids 1.3 Screening – Target CVD Risk Assessment – not NHS Healthcheck or LTC | This is a subdivision of the parent search that excludes those that could be in invited for an NHS Healthcheck or an LTC. These patients could potentially be missed from any routine recall but existing coding in the record suggests they would have a QRisk2>10%. |
Familial Hypercholesterolaemia Case Finding
| Search Name | Search Description |
| ?Lipids 2.0 Case Finding – Consider screening for familial hypercholesterolaemia | This search identifies patients based on the DLCN criteria, Simon Broome and NICE Plus citeria to identify patients who may have familial hypercholesterolaemia |
| ?Lipids 2.01 Case Finding – Consider screening fro FH (also eligible for IIF FH) | This is a subdivision of the parent search that identifies patients who also meet the PCN DES IIF FH indicator for referral for FH screening but excludes those in whom a referral has been made and coded. |
| ?Lipids 2.02 Case Finding – Consider screening for FH – highest risk patients | This subdivision of the parent search identifies those with the highest risk scores that are most likely to have FH. |
| ?Lipids 2.1 Case Finding – Eligible for IIF but FH less likely | This search identifies those patients currently identified by the PCN DES IIF FH indictors who are less likely to have FH and more likely to have secondary hyperlipidaemia. |
| ?Lipids 2.2 Case Finding – Code for FH but no genetic code – consider gene test | This search identifies patients have a possible/probable/FH code who do not have a genetic FH code diagnosis. These patients should be reviewed and genetic code added, or referral made, or removal of FH code if incorrect (e.g. Patient has secondary hyperlipidaemia). |
| ?Lipids 2.21 Case Finding – code for FH, no genetic test, eligible for IIF | This is a subdivision of the parent search identifying those patients in the PCN DES IIF denominator searches. These patients should be reviewed and genetic code added, or referral made, or removal of FH code if incorrect (e.g. Patient has secondary hyperlipidaemia). |
Lipid Management
| Search Name | Search Description |
| ?Lipids 3.1 Management – Consider lipid lowering for Secondary Prevention | This search identifies patients with manifest atherosclerosis who are not taking lipid lowering medication with no clear indication why. |
| ?Lipids 3.2 Management – Consider lipid lowering for Primary Prevention | This search identifies patients with coded reasons to be already on lipid lowering medication who are not. There are further subdivisions as shown above highlighting the indication for primary prevention. |
| ?Lipids 3.3 Management – Possible poor lipid lowering therapy concordance | This search identifies patient who are prescribed lipid lowering medication, but they have not has them issued in the last 3 months. |
| ?Lipids 4.1 Management – On lipid lowering – without a lipid target | This search identifies patients who are prescribed lipid lowering medication, but do not have a Non-HDL cholesterol target |
| ?Lipids 4.2 Management – On lipid lowering – has lipid target but not achieved | This search identifies patients who have not achieved their Non-HDL cholesterol target (if one is recorded) |
| ?Lipids 4.3 Management – On low/mod lipid lowering – consider intensification | This search identifies patient who are prescribed a low/moderate potency statin who should be prescribed a high intensity statin. |
| ?Lipids 4.3.1 Management – On low/mod lipid lowering (excl. target achieved) | This subdivision of the parent search excludes those patients on a low or moderate potency steroid who have achieved their target non-HDL cholesterol level. |
Lipid Management – Specialist Lipid input
| Search Name | Search Description |
| ?Lipids 5.1 Management – Consider lipid lowering – may more detailed input | Patients who appear to need lipid lowering but have had ADR to at least one statin AND ezetimibe – may need specialist input |
| ?Lipids 5.2 Management – Referral criteria for PCSK9i but poor concordance with current treatment | Fulfil referral criteria for PCSK9i therapy but may not be taking current lipid lowering therapy |
| ?Lipids 5.3 Management – Referral Criteria for PCSK9i – Consider primary care intensification | Fulfil referral criteria for PCSK9i therapy but there may be scope for intensification of lipid lowering therapy in primary care |
| ?Lipids 5.4 Management – Referral Criteria for PCSK9i – Consider referral | Likely to be eligible for PCSK9i referral |
| ?Lipids 5.5 Management – Referral criteria for Inclisiran but poor concordance with current treatment | Fulfil referral criteria for Inclisiran therapy but may not be taking current lipid lowering therapy |
| ?Lipids 5.6 Management – Referral Criteria for Inclisiran – Consider primary care intensification | Fulfil referral criteria for Inclisiran therapy but there may be scope for intensification of lipid lowering therapy in primary care |
| ?Lipids 5.7 Management – Referral Criteria for Inclisiran – Consider referral | Likely to be eligible for Inclisiran referral |
CDRC Lipid Management Template
The Lipid Management Template is an intelligent template that helps guide clinicians through their patient’s lipid management, presenting relevant information depending on whether it is for primary prevention, secondary prevention and whether or not they are at target.
To access the CDRC Lipid Management Template, you will need to have the CDRC Precision Resource Launcher enabled at your practice. Information on how to do this can be found by clicking on the link below:
Once enabled, you will be able to follow these steps:
- With the identified patient’s record retrieved, press F12 and select CDRC Precision Resource Launcher which will open the following pop-up:
- Click ‘OK’
- Click on Assessment and Management Templates > Cardiovascular > Lipids Management, which will open the following template:
This screenshot is for a dummy patient who is being treated for secondary prevention and provides information to support the management and optimisation of their treatment.
Additional pages are provided for FH Screening, where you can calculate the DCLN score and refer the patient for a FH assessment if required; Hyperlipidaemia Aetiology and LLT’s, containing information on potencies, cautions and medication suitability (adverse reactions, contraindicated, not tolerated).
Get in touch:
If you have any questions regarding access, or the use of the CDRC’s Resources, please get in touch: contact-CDRC@ahsn-nenc.org.uk